Sports Medicine

, Volume 18, Issue 2, pp 109–125 | Cite as

Caffeine and Endurance Performance

  • Mark A. Tarnopolsky
Review Article


Caffeine is consumed in many beverages and foods throughout the world. It is the most commonly used drug in North America and, probably, in many other countries. The short term consumption of caffeine may result in increased urination, gastrointestinal distress, tremors, decreased sleep, and anxiety symptoms in certain individuals. The long term consumption of caffeine at < 5 cups/day does not appear to increase the risk of cancer, cardiovascular disease, peptic ulcer disease or cardiac arrhythmias.

At the cellular level, caffeine is a competitive antagonist of adenosine receptors and probably acts directly on the ryanodine receptor (Ca++ release channel) to potentiate Ca++ release from skeletal muscle sarcoplasmic reticulum. As a result of these 2 cellular mechanisms of action, caffeine causes increased lipolysis, a facilitation of central nervous system transmission, a reduction in plasma potassium during exercise, an increased force of muscle contraction at lower frequencies of stimulation, and a sparing of muscle glycogen (partially or wholly due to an increase in free fatty acid oxidation). These mechanisms of action would predict that caffeine should be of ergogenic benefit during endurance exercise performance, especially when glycogen depletion would be rate limiting to performance. A review of the literature suggests that caffeine at doses of approximately 6 mg/kg is not of ergogenic benefit to high intensity exercise performance, but similar doses are ergogenic in endurance exercise performance. These doses (approximately 6 mg/kg) would result in urinary caffeine concentrations less than the current International Olympic Committee restricted level of 12 mg/L, and consideration should be given to lowering this level.


Caffeine Sarcoplasmic Reticulum Endurance Exercise Muscle Glycogen Respiratory Exchange Ratio 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Graham DM. Caffeine: its identity, dietary sources, intake and biological effects. Nutr Rev 1978; 36: 99–102Google Scholar
  2. 2.
    Curatolo PW, D Robertson. The health consequences of caffeine. Ann Intern Med 1983; 98: 641–53PubMedGoogle Scholar
  3. 3.
    Delbeke FT, M Debachere. Caffeine: use and abuse in sports. Int J Sports Med 1984; 5: 179–82PubMedGoogle Scholar
  4. 4.
    Boje O. Doping: Bulletin of the Health Organization of the League of Nations 1939; 8: 439–69Google Scholar
  5. 5.
    Venerando A. Doping: pathology and ways to control it. Med dello Sport 1963; 3: 972–83Google Scholar
  6. 6.
    Eichner ER. The caffeine controversy: effects on endurance and cholesterol. Physician Sportsmed 1986; 14: 124–32Google Scholar
  7. 7.
    Government of Canada (Fitness and Amateur Sport). Banned and restricted doping classes and methods. Ottawa: Minister of Supply and Services Canada 1989; H93–H103Google Scholar
  8. 8.
    Dodd SL, Herb RA, SK Powers. Caffeine and exercise performance: an update. Sports Med 1993; 15 (1): 14–23PubMedGoogle Scholar
  9. 9.
    Eichner ER. Ergolytic drugs in medicine and sports. Am J Med 1993; 94: 205–11PubMedGoogle Scholar
  10. 10.
    Goldstein A, Warren R, S Kaizer. Psychotropic effects of caffeine in man: I. Individual difference in sensitivity to caffeine-induced wakefulness. J Pharmacol Exp Ther 1965; 149: 156–9PubMedGoogle Scholar
  11. 11.
    Karacan I, Thornby JI, Anch AM, et al. Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther 1976; 20: 682–9PubMedGoogle Scholar
  12. 12.
    Brezinova V. Effect of caffeine on sleep: EEG studies in middle aged people. Br J Clin Pharmacol 1974; 1: 203–6PubMedGoogle Scholar
  13. 13.
    Regestein QR. Pathologic sleepiness induced by caffeine. Am J Med 1989; 87: 586–8PubMedGoogle Scholar
  14. 14.
    Galletly DC, Fennelly M, Whitwam JG. Does caffeine withdrawal contribute to postanesthetic morbidity? Lancet 1989; 1: 1335PubMedGoogle Scholar
  15. 15.
    van Dusseldorp M, Katan MB. Headache caused by caffeine withdrawl among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. BMJ 1990; 300: 1558–9PubMedGoogle Scholar
  16. 16.
    Persson CGA, Andersson KE, Kjellin G. Effects of enprofylline and theophylline may show the role of adenosine. Life Sci 1986; 38: 1057–72PubMedGoogle Scholar
  17. 17.
    Rall TW. Central nervous system stimulants. In: Goodman LS, Gilman AG, editors. The pharmacological basis of therapeutics. New York: MacMillan, 1985: 589–603Google Scholar
  18. 18.
    Gordon NF, Myburgh JL, Kruger PE, et al. Effects of caffeine ingestion on thermoregulatory and myocardial function during endurance performance. S Afr Med J 1982; 62: 644–7PubMedGoogle Scholar
  19. 19.
    Falk B, Burstein R, Rosenblum J, et al. Effects of caffeine ingestion on body fluid balance and thermoregulation during exercise. Can J Physiol Pharmacol 1990; 68: 889–92PubMedGoogle Scholar
  20. 20.
    James JE, KD Stirling. Caffeine: a survey of some of the known and suspected deleterious effects of habitual use. Br J Addiction 1983; 78: 251–8Google Scholar
  21. 21.
    Stillner V, Popkin MK, Pierce CM. Caffeine-induced delirium during prolonged competitive stress. Am J Psychiatry 1978; 135: 855–6PubMedGoogle Scholar
  22. 22.
    White BC, Lincoln CA, Pearce NW, et al. Anxiety and muscle tension as consequences of caffeine withdrawal. Science 1980; 209: 1547–8PubMedGoogle Scholar
  23. 23.
    Robertson D, Folich JC, Carr RK, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 1978; 298: 181–6PubMedGoogle Scholar
  24. 24.
    Robertson D, Hollister AS, Kincaid D, et al. Caffeine and hypertension. Am J Med 1984; 77: 54–9PubMedGoogle Scholar
  25. 25.
    Sung, BH, Lovallo WR, Pincomb GA, et al. Effect of caffeine on blood pressure response during exercise in normotensive healthy young men. Am J Cardiol 1990; 66: 909–13Google Scholar
  26. 26.
    Robertson D, Wade D, Workman R, et al. Tolerance to the humoral and hemodynamic effects of caffeine. J Clin Invest 1981; 67: 1111–7PubMedGoogle Scholar
  27. 27.
    Rosenberg L, Slone D, Shapiro S, et al. Coffee drinking and myocardial infarction in young women. Am J Epidemiol 1980; 111: 675–81PubMedGoogle Scholar
  28. 28.
    LaCroix AZ, Mead LA, Liang KY, et al. Coffee consumption and the incidence of coronary heart disease. N Engl J Med 1986; 315: 977–82PubMedGoogle Scholar
  29. 29.
    Grobbee DE, Rimm EB, Giovannucci E, et al. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 1990; 323 (15): 1026–32PubMedGoogle Scholar
  30. 30.
    Rosmarin PC. Coffee and coronary heart disease: a review. Prog Cardiovasc Dis 1989; 32: 239–45PubMedGoogle Scholar
  31. 31.
    Stavric B. An update on research with coffee/caffeine (1989–1990). Fd Chem Toxic 1992; 30 (6): 533–55Google Scholar
  32. 32.
    Chelsky LB, Cutler JE, Griffith K, et al. Caffeine and ventricular arrhythmias. An electicophysiological approach. JAMA 1990; 264: 2236–40PubMedGoogle Scholar
  33. 33.
    Graboys TB, Blatt CM, Lown B. The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia. Arch Int Med 1989; 149: 637–9Google Scholar
  34. 34.
    Heuch I, Kvale G, BK Jacobsen, et al. Use of alcohol, tobacco and coffee, and risk of pancreatic cancer. Br J Cancer 1983; 48: 637–43PubMedGoogle Scholar
  35. 35.
    Pozniak PC. The carcinogenicity of caffeine and coffee: a review. J Am Diet Assoc 1985; 85: 1127–32PubMedGoogle Scholar
  36. 36.
    IARC Working Group. IARC monographs in the evaluation of the carcinogenic risks to humans. Vol 51. Coffee, tea, mate, methylxanthines and methylglyoxal. Lyon: International Agency for Research on Cancer, 1991Google Scholar
  37. 37.
    Elta GH, Behler EM, Colturi TJ. Comparison of coffee intake and coffee-induced symptoms in patients with duodenal ulcer, nonulcer dyspepsia, and normal controls. Am J Gastroenterol 1990; 85: 1339–42PubMedGoogle Scholar
  38. 38.
    Bunker ML, McWilliams M. Caffeine content of common beverages. J Am Diet Assoc 1989; 74: 28–32Google Scholar
  39. 39.
    Bonati M, Latini R, Galletti F, et al. Caffeine disposition after oral doses. Clin Pharmacol Ther 1982; 32: 98–106PubMedGoogle Scholar
  40. 40.
    Powers SK, Byrd RJ, Tulley R, et al. Effects of caffeine ingestion and metabolism on performance during graded exercise. Eur J Appl Physiol 1983; 50: 301–7Google Scholar
  41. 41.
    Patwardhan RV, Desmond PV, Johnson RF, et al. Impaired elimination of caffeine by oral contraceptive steroids. J Lab Clin Med 1980; 95: 603–8PubMedGoogle Scholar
  42. 42.
    Cheng WSC, Murphy TL, Smith MT, et al. Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clin Pharmacol Ther 1990; 47: 516–24PubMedGoogle Scholar
  43. 43.
    Caraco Y, Zylber-Katz E, Granit L, et al. Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism. Biopharm Drug Dispos 1990; 11: 639–43PubMedGoogle Scholar
  44. 44.
    Axelrod J, Reichenthal J. The fate of caffeine in man and a method for its estimation in biological material. J Pharm Exp Ther 1953; 107: 519–23Google Scholar
  45. 45.
    Cornish HH, Christman AA. A study of the metabolism of theobromine, theophylline and caffeine in man. J Biol Chem 1957; 228: 315–23PubMedGoogle Scholar
  46. 46.
    Newton R, Broughton LJ, Lind MJ, et al. Plasma and salivary harmacokinetics of caffeine in man. Eur J Clin Pharmacol 1981; 21: 45–52PubMedGoogle Scholar
  47. 47.
    van der Merwe PJ, Luus HG, Barnard JG. Caffeine in sport. Influence of endurance exercise on the urinary caffeine concentration. Int J Sports Med 1992; 13 (1): 74–6PubMedGoogle Scholar
  48. 48.
    Graham TE, LL Spriet. Performance and metabolic responses to a high caffeine dose during prolonged exercise. J Appl Physiol 1991; 71 (6): 2292–8PubMedGoogle Scholar
  49. 49.
    Wagner JC. How much caffeine is too much in athletes? [correspondence]. Am J Hosp Pharmacy 1990; 47: 303Google Scholar
  50. 50.
    Duthel JM, Vallon JJ, Martin G, et al. Caffeine and sport: role of physical exercise upon elimination. Med Sci Sports Exerc 1991; 23 (8): 980–5PubMedGoogle Scholar
  51. 51.
    Fain JN. Cyclic nucleotides in adipose tissue. In: Cramer H, Schultz J, editors. Cyclic 3′,5′-nucleotides: mechanisms of action. London: J Wiley & Sons, 1977: 207–28Google Scholar
  52. 52.
    Zhang Y, Wells J. The effects of chronic caffeine administration on peripheral adenosine receptors. J Pharmacol Exp Ther 1990; 757–63Google Scholar
  53. 53.
    Daly JW, Bruns RF, Snyder SH. Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci 1981; 28: 2083–97PubMedGoogle Scholar
  54. 54.
    Guthrie JR, Nayler WG. Interaction between caffeine and adenosine on calcium exchangeability in mammalian atria. Arch Int Pharmacol Ther 1967; 170: 249–55Google Scholar
  55. 55.
    Coffin V, Spealman R. Behavioural and cardiovascular effects of analogs of adenosine in cynomogous monkeys. J Pharmacol Exp Ther 1987; 241: 76–83PubMedGoogle Scholar
  56. 56.
    Holtzman S, Mante S, Minneman K. Role of adenosine receptors in caffeine tolerance. J Pharmacol Exp Ther 1991; 256: 62–8PubMedGoogle Scholar
  57. 57.
    Fredholm B. On the mechanism of action of theophylline and caffeine. Acta Med Scand 1985; 217: 149–53PubMedGoogle Scholar
  58. 58.
    Scholfield CN. Depression of evoked potentials in brain slices by adenosine compounds. Br J Pharmacol 1978; 63: 239–44PubMedGoogle Scholar
  59. 59.
    Phillis JW, Wu PH. The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurosci 1981; 16: 187–239Google Scholar
  60. 60.
    Howell S, Jones DA, Mayor SJ. The action of caffeine and related compounds on skeletal muscle. Proc Physiol Soc 1981; 41: 24P–25PGoogle Scholar
  61. 61.
    Kramer GL, JN Wells. Xanthines and skeletal muscle: lack of relationship between phosphodiesterase inhibition and increased twitch tension in rat diaphragms. Mol Pharmacol 1980; 17: 73–8PubMedGoogle Scholar
  62. 62.
    Lai FA, Erickson HP, Rousseau E, et al. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature 1988; 331 (28): 315–9PubMedGoogle Scholar
  63. 63.
    Frank GB. Pharmacological studies of excitation-contraction coupling in skeletal muscle. Can J Physiol Pharmacol 1987; 65: 711–6PubMedGoogle Scholar
  64. 64.
    Fabiato A, Fabiato F. Dependence of the contractile activation of seived cardiac cells on the sarcomere length. Nature 1975; 256: 54–6PubMedGoogle Scholar
  65. 65.
    Weber A, Herz R. The relationship between caffeine contracture of intact muscle and the effect of caffeine on reticulum. J Gen Physiol 1968; 52: 750–9PubMedGoogle Scholar
  66. 66.
    Connett RJ, Ugol LM, Hammack MJ, et al. Twitch potentiation and caffeine contractures in isolated rat soleus muscle. Comp Biochem Physiol 1983; 74C: 349–54Google Scholar
  67. 67.
    Macintosh BR, Kupsh CC. Staircase, fatigue, and caffeine in skeletal muscle in situ. Muscle Nerve 1987; 10: 717–22PubMedGoogle Scholar
  68. 68.
    Weber A. The mechanism of the action of caffeine on sarcoplasmic reticulum. J Gen Physiol 1968; 52: 760–72PubMedGoogle Scholar
  69. 69.
    Fryer MW, Neering IR. Actions of caffeine on fast- and slow-twitch muscles of the rat. J Physiol 1989; 416: 435–54PubMedGoogle Scholar
  70. 70.
    Block BM, Barry SR, Faulkner JA. Aminophylline increases submaximal power but not intrinsic velocity of shortening of frog muscle. J Appl Physiol 1992; 73 (1): 71–4PubMedGoogle Scholar
  71. 71.
    Zavecz JH, Anderson WMcD. Role of extracellular Ca2+ in diaphragmatic contraction: effects of oubain, monensin, and ryanodine. J Appl Physiol 1992; 73 (1): 30–5PubMedGoogle Scholar
  72. 72.
    Penner R, Neher E, Takeshima H, et al. Functional expression of the calcium release channel from skeletal muscle ryanodine receptor cDNA. FEBS Lett 1989; 259 (1): 217–20PubMedGoogle Scholar
  73. 73.
    Gulati J, Babu A. Contraction kinetics of intact and skinned frog fibres and degree of activation. J Gen Physiol 1985; 86: 479–500PubMedGoogle Scholar
  74. 74.
    Wendt I, Stevenson D. Effects of caffeine on calcium activated force production in skinned cardiac and skeletal muscle fibers of the rat. Pflugers Archiv 1983; 398: 210–6PubMedGoogle Scholar
  75. 75.
    Palmer BM, Moore RL. Myosin light chain phosphorylation and tension potentiation in mouse skeletal muscle. Am J Physiol 1989; 257 (26): C1012–C1019PubMedGoogle Scholar
  76. 76.
    Ruff RL. Calcium sensitivity of fast- and slow-twitch human muscle fibers. Muscle Nerve 1989; 12: 32–7PubMedGoogle Scholar
  77. 77.
    Tarnopolsky MA, Brittain M. Neuromuscular effects of caffeine in habitual and non-habitual caffeine consumers. Can J Sport Sci 1989; 14 (4): 139PGoogle Scholar
  78. 78.
    Westerblad H, Duty S, Allen DG. Intracellular calcium concentration during low-frequency fatigue in isolated single fibers of mouse skeletal muscle. J Appl Physiol 1993; 75 (1): 382–8PubMedGoogle Scholar
  79. 79.
    Lindinger MI, Graham TE, Spriet LL. Caffeine attenuates the exercise-induced increase in plasma [K+] in humans. J Appl Physiol 1993; 74 (3): 1149–55PubMedGoogle Scholar
  80. 80.
    Clausen T, Flatman JA. The effect of catecholamines on Na-K transport and membrane potential in rat soleus muscle. J Physiol 1977; 270: 383–414PubMedGoogle Scholar
  81. 81.
    Rogus EM, Cheng LC, Zierler K. ß-Adrenergic effect on Na+-K+ transport in rat skeletal muscle. Biochim Biophysica Acta 1977; 464: 347–55Google Scholar
  82. 82.
    Lindinger MI, Heigenhauser GJF. The roles of ion fluxes in skeletal muscle fatigue. Can J Physiol Pharmacol 1991; 69: 246–53PubMedGoogle Scholar
  83. 83.
    Sjogaard G. Exercise-induced muscle fatigue: the significance of potassium. Acta Physiol Scand 1990; 593 Suppl.: 1–63Google Scholar
  84. 84.
    Green HJ, Chin ER, Ball-Burnett M, et al. Increases in human muscle Na+-K+-ATPase concentration with short-term training. Am J Physiol 1993; 264 (33): C1538–C1541PubMedGoogle Scholar
  85. 85.
    Rennie MJ, Winder WW, Holloszy JO. A sparing effect of in-creased plasma free fatty acids on muscle and liver glycogen content in the exercising rat. Biochem J 1976; 156: 647–55PubMedGoogle Scholar
  86. 86.
    Rennie MJ, Holloszy JO. Inhibition of glucose uptake and glycogenosis by availability of oleate in well-oxygenated perfused skeletal muscle. Biochem J 1977; 168: 161–70PubMedGoogle Scholar
  87. 87.
    Costill DL, Coyle E, Dalsky G, et al. Effects of elevated plasma FFA and insulin on muscle glycogen usage during exercise. J Appl Physiol 1977; 43: 695–9PubMedGoogle Scholar
  88. 88.
    Hultman E. Nutritional effects on work performance. Am J Clin Nutr 1989; 49: 949–57PubMedGoogle Scholar
  89. 89.
    O’Brien MJ, Viguie CA, Mazzeo RS, et al. Carbohydrate dependence during marathon running. Med Sci Sports Exerc 1993; 25 (9): 1009–17PubMedGoogle Scholar
  90. 90.
    Ravussin E, Bogardus C, Scheidegger K, et al. Effect of elevated FFA on carbohydrate and lipid oxidation during prolonged exercise in humans. J Appl Physiol 1986; 60 (3): 893–900PubMedGoogle Scholar
  91. 91.
    Hargreaves M, Kiens B, Richter EA. Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. J Appl Physiol 1991; 70 (1): 194–201PubMedGoogle Scholar
  92. 92.
    Costill DL, Dalsky GP, Fink WJ. Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports 1978; 10: 155–8PubMedGoogle Scholar
  93. 93.
    Ivy JL, Costill DL, Fink WJ, et al. Influence of caffeine and carbohydrate feedings on endurance performance. Med Sci Sports Exerc 1979; 11: 6–11Google Scholar
  94. 94.
    Giles D, MacLaren D. Effects of caffeine and glucose ingestion on metabolic and respiratory functions during prolonged exercise. J Sports Sci 1984; 2: 35–46Google Scholar
  95. 95.
    Fisher SM, McMurray RG, Berry M, et al. Influence of caffeine on exercise performance in habitual caffeine users. Int J Sports Med 1986; 7: 276–80PubMedGoogle Scholar
  96. 96.
    Sasaki H, Maeda J, Usui S, et al. Effect of sucrose and caffeine ingestion on performance of prolonged strenuous running. Int J Sports Med 1987; 8: 261–5PubMedGoogle Scholar
  97. 97.
    Sasaki H, Takaoka I, Ishiko T. Effects of sucrose or caffeine ingestion on running performance and biochemical responses to endurance running. Int J Sports Med 1987; 8: 203–7PubMedGoogle Scholar
  98. 98.
    Chad K, Quigley B. The effects of substrate utilization, manipulated by caffeine, on post-exercise oxygen consumption in untrained female subjects. Eur J Appl Physiol 1989; 59: 48–54Google Scholar
  99. 99.
    Tarnopolsky MA, Atkinson SA, MacDougall JD, et al. Physiological responses to caffeine during endurance exercise in habitual caffeine users. Med Sci Sports Exerc 1989; 21 (4): 418–24PubMedGoogle Scholar
  100. 100.
    Doubt TJ, Hsieh SS. Additive effects of caffeine and cold water during submaximal leg exercise. Med Sci Sports Exerc 1991; 23 (4): 435–42PubMedGoogle Scholar
  101. 101.
    Donelly K, McNaughton L. The effects of two levels of caffeine ingestion on postexercise oxygen consumption in untrained women. Eur J Appl Physiol 1992; 65: 459–63Google Scholar
  102. 102.
    Essig D, Costill DL, Van Handel PJ. Effects of caffeine ingestion on utilization of muscle glycogen and lipid during the ergometer cycling. Int J Sports Med 1980; 1: 86–90Google Scholar
  103. 103.
    Bangsbo J, Jacobsen K, Nordberg N, et al. Acute and habitual caffeine ingestion and metabolic responses to steady-state exercise. J Appl Physiol 1992; 72 (4): 1297–303PubMedGoogle Scholar
  104. 104.
    Spriet LL, MacLean DA, Dyck DJ, et al. Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am J Physiol 1990; 262 (25): E891–E898Google Scholar
  105. 105.
    Knapik JJ, Jones BH, Toner MM. Influence of caffeine on serum substrate changes during running in trained and untrained individuals. Biochem Exerc 1983; 13: 514–9Google Scholar
  106. 106.
    Weir J, Noakes TD, Myburgh K, et al. A high carbohydrate diet negates the metabolic effects of caffeine during exercise. Med Sci Sports Exerc 1987; 19: 100–5PubMedGoogle Scholar
  107. 107.
    Erickson MA, Schwarzkopf RJ, RD McKenzie. Effects of caffeine, fructose, and glucose ingestion on muscle glycogen utilization during exercise. Med Sci Sports Exerc 1987; 19: 579–83PubMedGoogle Scholar
  108. 108.
    Titlow LW, Ishee JH, Riggs CE. Failure of caffeine to affect metabolism during 60 min submaximal exercise. J Sports Sci 1991; 9: 15–22PubMedGoogle Scholar
  109. 109.
    Dodd SL, Brooks E, Powers SK, et al. The effects of caffeine on graded exercise performance in caffeine naive versus habituated subjects. Eur J Appl Physiol 1991; 62: 424–9Google Scholar
  110. 110.
    Casal DC, Leon AS. Failure of caffeine to affect substrate utilization during prolonged running. Med Sci Sports Exerc 1985; 17: 174–9PubMedGoogle Scholar
  111. 111.
    Oscai LB, Palmer WK. Muscle lipolysis during exercise: an update. Sports Med 1988; 6: 23–8PubMedGoogle Scholar
  112. 112.
    Hurley BF, Nemeth PM, Martin III WH, et al. Muscle triglyceride utilization during exercise: effect of training. J Appl Physiol 1986; 60 (2): 562–7PubMedGoogle Scholar
  113. 113.
    Romijn JA, Klein S, Coyle EF, et al. Strenuous endurance training increases lipolysis and triglyceride-fatty acid cycling at rest. J Appl Physiol 1993; 75 (1): 108–13PubMedGoogle Scholar
  114. 114.
    Lopes JM, Jardim AJ, Aranda JV, et al. Effect of caffeine on skeletal muscle function before and after fatigue. J Appl Physiol: Respirat Environ Exerc Physiol 1983; 54: 1303–5Google Scholar
  115. 115.
    Jacobson BH, Edwards SW. Effects of ingested doses of caffeine on neuromuscular reflex response time in man. Int J Sports Med 1990; 11: 194–7PubMedGoogle Scholar
  116. 116.
    Tarnopolsky MA, Hicks A, Cupido C, et al. Caffeine and neuromuscular function in humans: no effects of tolerance. Physiologist 1992; 35 (4): 201 (A30.15)Google Scholar
  117. 117.
    Edwards RHT, Hill DK, Jones DA, et al. Fatigue of long duration in human skeletal muscle after exercise. J Physiol 1977; 272: 769–78PubMedGoogle Scholar
  118. 118.
    Moussavi RS, Lehman SL, Miller RG. Dantrolene sodium and fatigue of long duration. Muscle Nerve 1992; 15: 384–9PubMedGoogle Scholar
  119. 119.
    Cupido CM, Hicks AL, Martin J. Neuromuscular fatigue during repetitive stimulation in elderly and young adults. Eur J Appl Physiol 1992; 65: 567–72Google Scholar
  120. 120.
    Grimby L, Hannerz J. Firing rate and recruitment order of toe extensor motor units in different modes of voluntary contraction. J Physiol 1977; 264: 865–79PubMedGoogle Scholar
  121. 121.
    Aubier M, DeTroyer A, Sampson M, et al. Aminophylline improves diaphragmatic contractility. N Engl J Med 1981; 305: 249–52PubMedGoogle Scholar
  122. 122.
    Supinski GS, Deal Jr EC, Kelsen SG. The effects of caffeine and theophylline on diaphragm contractility. Am Rev Respir Dis 1984; 130: 429–33PubMedGoogle Scholar
  123. 123.
    Supinski GS, Levin S, Kelsen SG. Caffeine effect on respiratory muscle endurance and sense of effort during loaded breathing. J Appl Physiol 1986; 60: 2040–7PubMedGoogle Scholar
  124. 124.
    D’Urzo AD, Jhirad R, Jenne H, et al. Effect of caffeine on ventilatory responses to hypercapnia, hypoxia, and exercise in humans. J Appl Physiol 1990; 68 (1): 322–8PubMedGoogle Scholar
  125. 125.
    Sutton JR, Reeves JT, Wagner PD, et al. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol 1988; 64 (4): 1309–21PubMedGoogle Scholar
  126. 126.
    Kivity S, Aharon YB, Man A, et al. The effect of caffeine on exercise-induced bronchoconstriction. Chest 1990; 97: 1083–5PubMedGoogle Scholar
  127. 127.
    Clubley M, Bye CE, Henson TA, et al. Effects of caffeine and cyclizine alone and in combination in human performance, subjective effects and EEG activity. Br J Clin Pharmacol 1979; 7: 157–63Google Scholar
  128. 128.
    Borg GA. Perceived exertion: a note on history and methods. Med Sci Sports Exerc 1973; 5: 90–3Google Scholar
  129. 129.
    Parry-Billings M, Bloomstrand E, McAndrew N, et al. A communicational link between skeletal muscle, brain, and cells of the immune system. Int J Sports Med 1990; 11 Suppl. 2: S122–S128PubMedGoogle Scholar
  130. 130.
    Wagenmakers AJM, Brookes JH, Coakley JH, et al. Exercise-induced activation of the branched-chain 2-oxo acid dehydrogenase in human muscle. Eur J Appl Physiol 1989; 59: 159–67Google Scholar
  131. 131.
    Arushanyan EB, Belozertsev YA, Aivazov KG. Comparative effect of amphetamine and caffeine on spontaneous activity of sensomotor cortical units and their responses to stimulation of the caudate nucleus. Bull Exp Biol Med 1975; 77: 776–9PubMedGoogle Scholar
  132. 132.
    Waldeck B. Sensitization by caffeine of central catecholamine receptors. J Neural Transm 1973; 34: 61–72PubMedGoogle Scholar
  133. 133.
    Oldendorf WH. Brain uptake of metabolites and drugs following carotid artery injections. Trans Am Neuro Assoc 1971; 96: 46–50Google Scholar
  134. 134.
    Berglund B, Hemmingsson P. Effects of caffeine ingestion on exercise performance at low and high altitudes in cross-country skiers. Int J Sports Med 1982; 3: 234–6PubMedGoogle Scholar
  135. 135.
    Perkins R, Williams MH. Effect of caffeine upon maximal muscular endurance of females. Med Sci Sports Exerc 1975; 7: 221–4Google Scholar
  136. 136.
    Tamopolsky MA, Atkinson SA, MacDougall JD, et al. Whole body leucine metabolism during and after resistance exercise in fed humans. Med Sci Sports Exerc 1991; 23 (3): 326–33Google Scholar
  137. 137.
    Conlee RK. Amphetamine, caffeine, and cocaine. In: Lamb, Murray, editors. Perspectives in exercise science and sports medicine. New York: Benchmark Press, 1990; 2: 285–310Google Scholar
  138. 138.
    Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown & Co, 1985Google Scholar
  139. 139.
    Tamopolsky LJ, MacDougall JD, Atkinson SA, et al. Gender differences in substrate for endurance exercise. J Appl Physiol 1990; 68 (1): 302–8Google Scholar
  140. 140.
    Phillips S, Atkinson SA, Tamopolsky MA, et al. Gender differences in leucine kinetics and nitrogen balance in endurance athletes. J Appl Physiol 1994; 75 (5): In pressGoogle Scholar
  141. 141.
    Williams JH. Caffeine, neuromuscular function and high-intensity exercise performance. J Sports Med Phys Fitness 1991; 31: 481–9PubMedGoogle Scholar
  142. 142.
    Toner MM, Kirkendall DT, Delio DJ, et al. Metabolic and cardiovascular responses to exercise with caffeine. Ergonomics 1982; 25: 1175–83PubMedGoogle Scholar
  143. 143.
    Gaesser GA, Rich RG. Influence of caffeine on blood lactate responses during incremental exercise. Int J Sports Med 1985; 6: 207–11PubMedGoogle Scholar
  144. 144.
    Bond V, Adams R, Balkissoon B, et al. Effects of caffeine on cardiorespiratory function and glucose metabolism during rest and graded exercise. J Sports Med 1987; 27: 47–52Google Scholar
  145. 145.
    Flinn S, Gregory J, McNaughton LR, et al. Caffeine ingestion prior to incremental cycling to exhaustion in recreational cyclists. Int J Sports Med 1990; 11 (3): 188–93PubMedGoogle Scholar
  146. 146.
    Anselme F, Collomp K, Mercier B, et al. Caffeine increases maximal anaerobic power and blood lactate concentration. Eur J Appl Physiol 1992; 65: 188–91Google Scholar
  147. 147.
    Collomp K, Ahmaidi S, Audran M, et al. Effects of caffeine ingestion on performance and anaerobic metabolism during the Wingate test. Int J Sports Med 1991; 12 (5): 439–43PubMedGoogle Scholar
  148. 148.
    Collomp K, Ahmidi S, Chatard JC, et al. Benefits of caffeine ingestion on sprint performance in trained and untrained swimmers. Eur J Appl Physiol 1992; 64: 377–80Google Scholar
  149. 149.
    Cadarette BS, Levine L, Beruhe CL, et al. Effects of varied dosages of caffeine on endurance exercise to fatigue. Biochem Exerc 1983; 13: 871–7Google Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Mark A. Tarnopolsky
    • 1
  1. 1.Department of Physical Medicine and RehabilitationHenderson General HospitalHamiltonCanada

Personalised recommendations